STIM onTrack icon

3.1.0 by Orthofix BioStim


Jun 4, 2024

About STIM onTrack

STIM onTrack™ provides tools for patients to help them use their BGS daily.

Orthofix Bone Growth Stimulation Therapy devices are prescribed by physicians to improve fracture healing and spinal fusion success rates.

The STIM onTrack™ mobile app provides tools and information for patients to help them use their bone growth therapy device daily as prescribed by their physician.

STIM onTrack app features for patients:

• Create a daily treatment reminder

• View a duplicate display of their device

• Daily treatment calendar

• Connect with an Orthofix Sales Rep or Patient Services with one-touch calling

• Link to read answers to commonly asked questions

• Learn how Orthofix Bone Growth Stimulation Therapy devices help improve fracture healing and spinal fusion success rates

• Access to standardized Patient Reported Outcomes Measure (PROM) questionnaires

For more information, visit BoneGrowthTherapy.com

STIM onTrack mobile app is intended for U.S. Residents only.

Orthofix products or services referenced herein are trademarks or registered trademarks of Orthofix Medical Inc. and its group of companies. Any rights not expressly granted herein are reserved.

What's New in the Latest Version 3.1.0

Last updated on Jun 4, 2024

- Update to UI
- Update to Treatment Reminders
- Connect with Social Media
- Bug fixes

Translation Loading...

Additional APP Information

Latest Version

Request STIM onTrack Update 3.1.0

Uploaded by

Yar Ma

Requires Android

Android 8.0+

Available on

Get STIM onTrack on Google Play

Show More

STIM onTrack Screenshots

Comment Loading...
Languages
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.